Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab.
Bond
Jonathan
J
Shahdadpuri
Raveen
R
Mc Mahon
Corrina
C
O'marcaigh
Aengus
A
Cotter
Melanie
M
Smith
Owen
O
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000821:virology; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome; D019562:Viral Load
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab